Cite
HARVARD Citation
Liang, D. et al. (2021). Efficacy of lenalidomide for relapsed or refractory T lymphoblastic lymphoma/leukemia after allogeneic hematopoietic stem cell transplantation. Leukemia & lymphoma. 62 (10), pp. 2521-2525. [Online].